Mortality risk associated with ejection fraction differs across resting nuclear perfusion findings

Journal of Nuclear Cardiology

Volumn 14, Issue 2, 2007, Pages 165-173

  Bourque, Jamieson M ^a   Velazquez, Eric J ^a   Tuttle, Robert H ^b   Shaw, Linda K ^b   O'Connor, Christopher M ^a   Borges Neto, Salvador ^a  

^a DUKE UNIVERSITY HEALTH SYSTEM   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

coronary artery disease; ejection fraction; Myocardial perfusion imaging; single photon emission computed tomography

Indexed keywords

TECHNETIUM 99M; THALLIUM 201;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CAUSE OF DEATH; CORRELATIONAL STUDY; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBER MEMBRANE STEADY POTENTIAL; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL RATE; SURVIVAL TIME;

AGED; COHORT STUDIES; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NORTH CAROLINA; PERFUSION; RISK ASSESSMENT; RISK FACTORS; STATISTICS; STROKE VOLUME; SURVIVAL ANALYSIS; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33947410410     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2006.11.011     Document Type: Article

References (33)

1. American Heart Association. Heart disease and stroke statistics-2002 update (2001), American Heart Association, Dallas (TX)
2. Sharir T., Germano G., Kavanagh P.B., Lai S., Cohen I., Lewin H.C., et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 100 (1999) 1035-1042
3. Aronow W.S., Ahn C., and Kronzon I. Prognosis of congestive heart failure after prior myocardial infarction in older men and women with abnormal versus normal left ventricular ejection fraction. Am J Cardiol 85 (2000) 1382-1384
4. Bourque J.M., Velazquez E.J., Borges-Neto S., Shaw L.K., Whellan D.J., and O'Connor C.M. Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?. Am Heart J 145 (2003) 758-767
5. Vanzetto G., Ormezzano O., Fagret D., Comet M., Denis B., and Machecourt J. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6-year follow-up. Circulation 100 (1999) 1521-1527
6. Zhu W.X., Gibbons R.J., Bailey K.R., and Gersh B.J. Predischarge exercise radionuclide angiography in predicting multivessel coronary artery disease and subsequent cardiac events after thrombolytic therapy for acute myocardial infarction. Am J Cardiol 74 (1994) 554-559
7. Oh J.K., Gibbons R.J., Christian T.F., Gersh B.J., Click R.L., Sitthisook S., et al. Correlation of regional wall motion abnormalities detected by two-dimensional echocardiography with perfusion defect determined by technetium 99m sestamibi imaging in patients treated with reperfusion therapy during acute myocardial infarction. Am Heart J 131 (1996) 32-37
8. Iskandrian A.S., Hakki A.H., and Kane-Marsch S. Prognostic implications of exercise thallium-201 scintigraphy in patients with suspected or known coronary artery disease. Am Heart J 110 (1985) 135-143
9. Hachamovitch R., Berman D.S., Kiat H., Cohen I., Cabico J.A., Friedman J., et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 93 (1996) 905-914
10. Hachamovitch R., Berman D.S., Shaw L.J., Kiat H., Cohen I., Cabico J.A., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97 (1998) 535-543
11. Borges-Neto S., Shaw L.K., Tuttle R.H., Alexander J.H., Smith IV W.T., Chambless M., et al. Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease. Am J Cardiol 95 (2005) 182-188
12. Kang X., Berman D.S., Van Train K.F., Amanullah A.M., Areeda J., Friedman J.D., et al. Clinical validation of automatic quantitative defect size in rest technetium-99m-sestamibi myocardial perfusion SPECT. J Nucl Med 38 (1997) 1441-1446
13. Cuocolo A., Acampa W., Nicolai E., Pace L., Petretta M., and Salvatore M. Quantitative thallium-201 and technetium 99m sestamibi tomography at rest in detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction. J Nucl Cardiol 7 (2000) 8-15
14. Gioia G., Milan E., Giubbini R., DePace N., Heo J., and Iskandrian A.S. Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 3 (1996) 150-156
15. Allman K.C., Shaw L.J., Hachamovitch R., and Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 (2002) 1151-1158
16. Bourque J.M., Hasselblad V., Velazquez E.J., Borges-Neto S., and O'Connor C.M. Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis. Am Heart J 146 (2003) 621-627
17. Bourque J.M., Velazquez E.J., Borges-Neto S., Shaw L.K., Whellan D.J., and O'Connor C.M. Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?. Am Heart J 145 (2003) 758-767
18. Gonzalez J.M., Castell-Conesa J., Candell-Riera J., Rossello-Urgell J., and Spanish Working Group of Nuclear Cardiology. Relevance of 99mTc-MIBI rest uptake, ejection fraction and location of contractile abnormality in predicting myocardial recovery after revascularization. Nucl Med Commun 22 (2001) 795-805
19. Borges-Neto S. Perfusion and function assessment by nuclear cardiology techniques. Curr Opin Cardiol 12 (1997) 581-586
20. Bart B.A., Shaw L.K., McCants Jr. C.B., Fortin D.F., Lee K.L., Califf R.M., et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30 (1997) 1002-1008
21. O'Connor C.M., Gattis W.A., Shaw L., Cuffe M.S., and Califf R.M. Clinical characteristics and long-term outcomes of patients with heart failure and preserved systolic function. Am J Cardiol 86 (2000) 863-867
22. Rosati R.A., McNeer J.F., Starmer C.F., Mittler B.S., Morris Jr. J.J., and Wallace A.G. A new information system for medical practice. Arch Intern Med 135 (1975) 1017-1024
23. Harris P.J., Harrell Jr. F.E., Lee K.L., Behar V.S., and Rosati R.A. Survival in medically treated coronary artery disease. Circulation 60 (1979) 1259-1269
24. Pryor D.B., Shaw L., Harrell Jr. F.E., Lee K.L., Hlatky M.A., Mark D.B., et al. Estimating the likelihood of severe coronary artery disease. Am J Med 90 (1991) 553-562
25. Shaw L.J., Hachamovitch R., Heller G.V., Marwick T.H., Travin M.I., Iskandrian A.E., et al., The Economics of Noninvasive Diagnosis (END) Study Group. Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. Am J Cardiol 86 (2000) 1-7
26. Harris P.J., Harrell Jr. F.E., Lee K.L., and Rosati R.A. Nonfatal myocardial infarction in medically treated patients with coronary artery disease. Am J Cardiol 46 (1980) 937-942
27. Kaplan E.J., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
28. Emond M., Mock M.B., Davis K.B., Fisher L.D., Holmes Jr. D.R., Chaitman B.R., et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 90 (1994) 2645-2657
29. Quinones M.A., Greenberg B.H., Kopelen H.A., Koilpillai C., Limacher M.C., Shindler D.M., et al. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 35 (2000) 1237-1244
30. Felker G.M., Thompson R.E., Hare J.M., Hruban R.H., Clemetson D.E., Howard D.L., et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342 (2000) 1077-1084
31. Schwarz E.R., Schoendube F.A., Kostin S., Schmiedtke N., Schulz G., Buell U., et al. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol 31 (1998) 1018-1026
32. Anversa P., Zhang X., Li P., and Capasso J.M. Chronic coronary artery constriction leads to moderate myocyte loss and left ventricular dysfunction and failure in rats. J Clin Invest 89 (1992) 618-629
33. American Society of Nuclear Cardiology. Updated imaging guidelines for nuclear cardiology procedures, part 1. J Nucl Cardiol 8 (2001) G5-G58